bluebird bio, Inc. (BLUE) Social Stream



bluebird bio, Inc. (BLUE): $3.90

0.04 (+1.04%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add BLUE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#308 of 342

in industry

BLUEBIRD BIO INC (BLUE) Price Targets From Analysts

Use the tables below to see what analysts covering BLUEBIRD BIO INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 14 $45 $11 $23.09 $3.83 502.87%
2021-11-15 14 $45 $11 $22.8 $3.83 495.3%
2021-11-19 14 $45 $11 $20.2 $3.83 427.42%
2021-12-20 13 $45 $11 $20.2 $3.83 427.42%
2022-01-06 13 $45 $10 $20.1 $3.83 424.8%
2022-01-18 13 $45 $10 $19.9 $3.83 419.58%
2022-02-01 13 $45 $6 $19.5 $3.83 409.14%
2022-03-07 12 $45 $6 $19.5 $3.83 409.14%
2022-03-09 13 $45 $4 $18.333 $3.83 378.67%
2022-05-03 13 $45 $4 $18.111 $3.83 372.87%
2022-05-10 13 $35 $4 $14.625 $3.83 281.85%
2022-05-17 13 $35 $3 $14.25 $3.83 272.06%
2022-06-12 13 $25 $2 $10.125 $3.83 164.36%
2022-08-08 12 $23 $2 $8.25 $3.83 115.4%
2022-08-13 10 $23 $2 $8.25 $3.83 115.4%
2022-08-19 10 $23 $2 $8.5 $3.83 121.93%
2022-09-13 10 $23 $3 $8.625 $3.83 125.2%
2022-09-19 10 $23 $3 $8.75 $3.83 128.46%
2022-09-20 10 $23 $3 $9 $3.83 134.99%
2022-10-12 9 $10 $3 $7 $3.83 82.77%
2022-10-24 9 $10 $3 $6.714 $3.83 75.3%
2022-11-08 10 $10 $3 $6.714 $3.83 75.3%
2023-01-24 10 $10 $3 $7 $3.83 82.77%
2023-02-08 10 $10 $3 $6.875 $3.83 79.5%
2023-03-07 11 $10 $3 $7.222 $3.83 88.56%
2023-03-30 11 $10 $3 $6.555 $3.83 71.15%
2023-04-13 11 $10 $3 $6.222 $3.83 62.45%
2023-05-10 12 $10 $3 $6.3 $3.83 64.49%
2023-06-06 12 $10 $3 $6.8 $3.83 77.55%
2023-07-13 12 $10 $3 $6.9 $3.83 80.16%
2023-08-08 12 $11 $3 $7.3 $3.83 90.6%
2023-08-16 11 $11 $3 $7.888 $3.83 105.95%
2023-10-12 12 $11 $3 $7.521 $3.83 96.37%
2023-11-07 12 $11 $3 $7.321 $3.83 91.15%
2023-11-08 12 $13 $3 $7.421 $3.83 93.76%

The Trend in the Analyst Price Target


Over the past 15 months, BLUE's average price target has gone down $1.2.

Over the past 43 weeks, BLUE's average upside potential has been 94.43%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-10 12 10 3 6.500 5.03 29.22%
2023-08-08 12 11 3 7.300 3.89 87.66%
2023-08-08 12 11 3 7.400 3.89 90.23%
2023-09-06 11 11 3 7.521 3.80 97.92%
2023-10-12 12 11 3 7.521 2.61 188.16%

BLUE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.31 4 1 6 0 0 12

The Trend in the Broker Recommendations


BLUE's average broker recommendation rating improved by 0.5 over the prior 26 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BLUE as an investment opportunity.

  • In the context of all US stocks, BLUEBIRD BIO INC's variance in analysts' estimates is lower than -4633.99% of them.
  • In terms of how BLUEBIRD BIO INC fares relative to stocks in the large market cap category, note that its average analyst price target is greater than 276.14% of that group.
  • BLUE has a higher upside potential (average analyst target price relative to current price) than 4526.36% of stocks in the large market cap category.
  • BLUE has a greater number of analysts covering the stock than 3917.65% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, SGEN, NVAX, and NBIX are the three stocks most similar to BLUEBIRD BIO INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding BLUE using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!